MVIIIHealth The MVIII app
← Back

Research · Daily life

Daily steps

Pooled cohorts link more daily steps to fewer deaths and less heart disease, with risk falling steeply up to about 6,000 to 8,000 steps a day in older adults and 8,000 to 10,000 in younger adults, then leveling off. In trials, step counters added about 1,800 to 2,500 steps a day and about 1 kg of weight loss.

Checked 2026-11-13
Status
A daily life factor, not a product.
Also called
step count, steps per day, 10,000 steps, 10000 steps, 7,000 steps, walking, pedometer, step counter, step goal, activity tracker steps, daily walking
Studied for
living longer, heart health, diabetes prevention, blood sugar, weight loss, blood pressure, mood, depression, memory, dementia prevention, fitness, fewer falls

Strong several reviews agree · Moderate one review or consistent trials · Limited one or a few small studies · Untested no study in people, listed with what it rests on

Shown to help7

Reported risks0

No risks sourced yet.

What it was studied for, and what was found

Shown to help7

Strong

Death from any cause

Linked to progressively fewer deaths with more daily steps in pooled cohorts, leveling off at about 6,000 to 8,000 steps in adults 60 and older.

Compared with people in the lowest quarter of steps, a median of 3,553 a day [1]; people in the reference quarter, a median of 3,867 steps a day [2]; 2,000 steps a day [3][4]; taking 4,000 steps a day [5]

The numbers and sources
Effect
Against the lowest quarter, the hazard of death was 0.60 at a median of 5,801 steps, 0.55 at 7,842 and 0.47 at 10,901 (95% CI 0.39 to 0.57). Risk fell until 6,000 to 8,000 steps a day in adults aged 60 and older, and until 8,000 to 10,000 in younger adults [1]. Each extra 1,000 steps was linked to 15% lower mortality (HR 0.85, 95% CI 0.81 to 0.91) [2]. Risk was significantly lower from 2,517 steps a day (HR 0.92), with the largest drop at about 8,763 steps (HR 0.40, 95% CI 0.38 to 0.43) [3]. Against 2,000 steps, 7,000 was linked to 47% lower mortality (HR 0.53, 95% CI 0.46 to 0.60), with an inflection at about 5,000 to 7,000 [4]. In US adults, 8,000 steps (HR 0.49) and 12,000 steps (HR 0.35) were linked to lower mortality than 4,000 [5].
Population
47,471 adults in 15 cohorts with 3,013 deaths, median follow-up 7.1 years [1]. 226,889 participants in 17 cohorts [2]. 111,309 people in 12 studies [3]. 14 studies in the mortality analysis, from 57 studies of 35 cohorts [4]. 4,840 US adults aged 40 and older, followed a mean of 10.1 years [5].
Sources
[1], [2], [3], [4], [5]
Caveats
Observational, with steps measured by a device for about a week. Confounding by health and income is possible, and reverse causation is likely in part: illness and frailty lower step counts before death. Results depended on where the device was worn [3]. After adjusting for total steps, faster stepping was not linked to lower mortality in one cohort (HR 0.90, 95% CI 0.65 to 1.27) [5], while peak 30-minute cadence kept a link in another analysis (HR 0.67) [1].
Strong

Heart disease and stroke

Linked to less cardiovascular disease with more daily steps in pooled cohorts, a clear pattern in adults 60 and older and no clear pattern in younger adults.

Compared with people in the lowest quarter of steps [6]; 2,000 steps a day [3][4]; people in the lowest quarter, a median of 2,337 steps a day [2]

The numbers and sources
Effect
In adults aged 60 and older, cardiovascular disease risk against the lowest quarter was 0.80 in the second quarter, 0.62 in the third and 0.51 in the highest (95% CI 0.41 to 0.63). In adults under 60 the hazards were 0.79, 0.90 and 0.95, none significant [6]. Risk of new cardiovascular disease was lower from 2,735 steps a day (HR 0.89) and lowest near 7,126 steps (HR 0.49, 95% CI 0.45 to 0.55) [3]. Against 2,000 steps, 7,000 steps was linked to 25% fewer new cases (HR 0.75, 95% CI 0.67 to 0.85) and 47% fewer cardiovascular deaths (HR 0.53, 95% CI 0.37 to 0.77) [4]. Each extra 500 steps was linked to 7% lower cardiovascular mortality (HR 0.93, 95% CI 0.91 to 0.95) [2].
Population
20,152 adults in 8 cohorts, mean age 63.2, 1,523 events over a mean 6.2 years [6]. 111,309 people in 12 studies [3]. 6 studies for new disease and 3 for deaths [4]. 226,889 participants in 17 cohorts [2].
Sources
[6], [3], [4], [2]
Caveats
Observational. Early heart disease can lower activity before diagnosis, which is reverse causation. Heterogeneity was high for cardiovascular deaths (I² 78.2%), and certainty was rated low for that outcome [4].
Moderate

Depressive symptoms

Linked to 22% fewer people with depressive symptoms at 7,000 steps a day than at 2,000, in one meta-analysis of three cohorts.

Compared with 2,000 steps a day [4]

The numbers and sources
Effect
Against 2,000 steps a day, 7,000 steps was linked to a 22% lower risk of depressive symptoms (HR 0.78, 95% CI 0.73 to 0.83), with a linear pattern. Certainty was rated moderate [4].
Population
3 cohort studies [4].
Sources
[4]
Caveats
Observational and only three studies. Low mood itself lowers activity, so reverse causation is likely in part.
Moderate

Dementia

Linked to 38% less dementia at 7,000 steps a day than at 2,000, in one meta-analysis of two cohorts.

Compared with 2,000 steps a day [4]

The numbers and sources
Effect
Against 2,000 steps a day, 7,000 steps was linked to a 38% lower risk of dementia (HR 0.62, 95% CI 0.53 to 0.73, I² 0%), with a non-linear pattern [4].
Population
2 cohort studies [4].
Sources
[4]
Caveats
Observational and only two studies. Dementia develops for years before diagnosis and lowers activity in that time, so reverse causation is a strong candidate.
Limited

Falls

Limited evidence: one meta-analysis linked 7,000 steps a day to 28% fewer falls than 2,000, at very low certainty.

Compared with 2,000 steps a day [4]

The numbers and sources
Effect
Against 2,000 steps a day, 7,000 steps was linked to a 28% lower risk of falls (HR 0.72, 95% CI 0.65 to 0.81), with an inflection at about 5,000 to 7,000 steps [4].
Population
4 cohort studies [4].
Sources
[4]
Caveats
The review rated certainty very low [4]. People with poor balance or past falls walk less, which is reverse causation.
Strong

Activity and fitness in step-count programs

Shown to add about 1,800 to 2,500 steps a day in trials of pedometers and activity trackers, with a small gain in fitness.

Compared with control participants [8]; control groups the source does not describe [9]; control groups in randomized trials [10]

The numbers and sources
Effect
In randomized trials, pedometer users raised their activity by 2,491 steps a day more than controls (95% CI 1,098 to 3,885). Having a step goal such as 10,000 steps predicted a larger rise [8]. Across 39 reviews, activity trackers raised physical activity (SMD 0.3 to 0.6), about 1,800 extra steps a day, and fitness (SMD 0.3) [9]. In people with type 2 diabetes, step counters added 1,822 steps a day (95% CI 751 to 2,894), and 3,200 when paired with a goal [10].
Population
2,767 participants in 26 studies, 8 of them randomized, mean age 49, 85% women, mean 18 weeks [8]. 163,992 participants in 39 reviews of all ages [9]. 861 people with type 2 diabetes in 7 trials [10].
Sources
[8], [9], [10]
Caveats
People in trials could not be blinded to wearing a counter. Programs lasted months, and the earliest review called long-term durability undetermined [8].
Moderate

Weight in step-count programs

Shown to lower weight by about 1 kg in walking programs built on a step counter, measured mostly before and after in the same people.

Compared with before the program, in the same people [11]; before the program in the same people, and control participants, pooled together [8]; control groups the source does not describe [9]

The numbers and sources
Effect
Across 9 pedometer walking programs without a diet change, weight fell by 1.27 kg from baseline (95% CI -1.85 to -0.70), about 0.05 kg a week, with more loss in longer programs [11]. Pooling all studies, body mass index fell by 0.38 (95% CI 0.05 to 0.72) [8]. Activity tracker reviews reported about 1 kg less body weight [9].
Population
307 participants in 9 cohorts, 73% women, 4 weeks to 1 year [11]. 2,767 participants in 26 studies [8]. 39 reviews [9].
Sources
[11], [8], [9]
Caveats
Small changes, mostly measured before and after in the same people, with no group left without a counter in most programs [11].

Mixed results4

Moderate

Type 2 diabetes

Mixed results: one meta-analysis linked 7,000 steps a day to 14% less type 2 diabetes than 2,000, while an earlier review found inconsistent results for blood sugar outcomes.

Compared with 2,000 steps a day [4]; lower step counts at baseline, as each study compared them [7]

The numbers and sources
Effect
Against 2,000 steps a day, 7,000 was linked to 14% lower risk of type 2 diabetes (HR 0.86, 95% CI 0.74 to 0.99), with a linear pattern [4]. An earlier systematic review of 8 studies of diabetes, insulin sensitivity, fasting glucose and HbA1c reported inconsistent findings, which it put down partly to differences in markers, analysis and samples [7].
Population
4 studies in the diabetes meta-analysis [4]. Over 30,000 adults in 17 prospective studies, 8 on blood sugar outcomes with 3 months to 5 years of follow-up [7].
Sources
[4], [7]
Caveats
Observational and few studies. The upper confidence limit sits close to no difference [4]. Weight, diet and early disease may affect both steps and diabetes risk.
Moderate

Cancer

Mixed results: one meta-analysis linked 7,000 steps a day to 37% fewer cancer deaths than 2,000, and found no significant difference in new cancers.

Compared with 2,000 steps a day [4]

The numbers and sources
Effect
Against 2,000 steps a day, 7,000 steps was linked to 37% lower cancer mortality (HR 0.63, 95% CI 0.55 to 0.72) and a non-significant 6% lower cancer incidence (HR 0.94, 95% CI 0.87 to 1.01) [4].
Population
3 studies for cancer deaths and 2 for new cancers [4].
Sources
[4]
Caveats
Observational and few studies. Heterogeneity was 64.5% for cancer deaths and 73.7% for new cancers, and certainty for new cancers was rated low [4]. Cancer can lower activity before it is diagnosed.
Moderate

Blood pressure in step-count programs

Mixed results: one review found systolic pressure fell 3.8 mmHg with pedometer programs, while reviews of activity trackers found blood pressure effects small and often not significant.

Compared with before the program in the same people, and control participants, pooled together [8]; control groups the source does not describe [9]

The numbers and sources
Effect
Pedometer program participants lowered systolic blood pressure by 3.8 mmHg (95% CI 1.7 to 5.9), more so when starting pressure was higher [8]. Across 39 reviews of activity trackers, effects on blood pressure, cholesterol and HbA1c were typically small and often not significant [9].
Population
2,767 participants in 26 studies [8]. 163,992 participants in 39 reviews [9].
Sources
[8], [9]
Caveats
The blood pressure figure pools randomized and observational studies [8]. The umbrella review gives no pooled blood pressure number in its abstract [9].
Moderate

HbA1c in people with type 2 diabetes using step counters

Mixed results: two meta-analyses found no change in HbA1c with step counters in type 2 diabetes, and a later one of 24 trials found a 0.22% drop.

Compared with control groups in randomized trials [10]; control groups in controlled trials [12]; control participants [13]

The numbers and sources
Effect
Step counter use did not change HbA1c (WMD 0.02%, 95% CI -0.08 to 0.13), with or without a goal [10]. A review of 12 trials found no differences in HbA1c, BMI, blood pressure or lipids [12]. A review of 24 randomized trials found HbA1c fell 0.22% (95% CI -0.4 to -0.05, I² 77%) and triglycerides fell 13.11 mg/dL (95% CI -25.21 to -1.02) against control participants [13].
Population
1,423 participants in 10 trials [10]. 1,458 participants in 12 trials [12]. 1,969 patients in 24 trials [13].
Sources
[10], [12], [13]
Caveats
All participants had type 2 diabetes. Heterogeneity was high in the positive review [13].

Amounts studied

The cohort meta-analyses measured steps with a device worn for about a week. In the largest pooled cohort analysis, quarters had medians of 3,553, 5,801, 7,842 and 10,901 steps a day [1]. Other reviews used 2,000 steps a day as the reference [3][4] and reported against 7,000 steps [4], or compared 4,000, 8,000 and 12,000 steps [5]. Where risk stopped falling: about 6,000 to 8,000 steps in adults 60 and older and 8,000 to 10,000 in younger adults [1], about 8,800 steps for death and 7,100 for cardiovascular disease [3], and an inflection at about 5,000 to 7,000 [4].

Step-count programs gave people a pedometer or tracker, often with a goal such as 10,000 steps a day, for a mean of 18 weeks [8] or 4 weeks to 1 year [11]. Trials in type 2 diabetes ran at least 2 weeks [13].

Claims tested and not found

  1. That 10,000 steps a day is the point where benefits start. Death rates fell from about 2,500 steps a day [3] and leveled off at 6,000 to 8,000 steps in adults 60 and older [1]. A review of 57 studies placed the inflection at about 5,000 to 7,000 steps [4].
  2. That more steps lower heart disease risk in younger adults. In adults under 60, the higher quarters of steps had no significantly lower cardiovascular risk (HR 0.95, 95% CI 0.61 to 1.48 in the top quarter) [6].
  3. That a step counter alone lowers HbA1c in type 2 diabetes. Two meta-analyses found no change in HbA1c [10][12], though a third found a small drop [13].

Sources

  1. Paluch AE, Bajpai S, Bassett DR, et al. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet Public Health. 2022. https://doi.org/10.1016/S2468-2667(21)00302-9
  2. Banach M, Lewek J, Surma S, et al. The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis. European Journal of Preventive Cardiology. 2023. https://doi.org/10.1093/eurjpc/zwad229
  3. Stens NA, Bakker EA, Mañas A, et al. Relationship of Daily Step Counts to All-Cause Mortality and Cardiovascular Events. Journal of the American College of Cardiology. 2023. https://doi.org/10.1016/j.jacc.2023.07.029
  4. Ding D, Nguyen B, Nau T, et al. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. The Lancet Public Health. 2025. https://doi.org/10.1016/S2468-2667(25)00164-1
  5. Saint-Maurice PF, Troiano RP, Bassett DR, et al. Association of Daily Step Count and Step Intensity With Mortality Among US Adults. JAMA. 2020. https://doi.org/10.1001/jama.2020.1382
  6. Paluch AE, Bajpai S, Ballin M, et al. Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis. Circulation. 2023. https://doi.org/10.1161/CIRCULATIONAHA.122.061288
  7. Hall KS, Hyde ET, Bassett DR, et al. Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia. International Journal of Behavioral Nutrition and Physical Activity. 2020. https://doi.org/10.1186/s12966-020-00978-9
  8. Bravata DM, Smith-Spangler C, Sundaram V, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA. 2007. https://doi.org/10.1001/jama.298.19.2296
  9. Ferguson T, Olds T, Curtis R, et al. Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses. The Lancet Digital Health. 2022. https://doi.org/10.1016/S2589-7500(22)00111-X
  10. Qiu S, Cai X, Chen X, et al. Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials. BMC Medicine. 2014. https://doi.org/10.1186/1741-7015-12-36
  11. Richardson CR, Newton TL, Abraham JJ, et al. A meta-analysis of pedometer-based walking interventions and weight loss. Annals of Family Medicine. 2008. https://doi.org/10.1370/afm.761
  12. Baskerville R, Ricci-Cabello I, Roberts N, Farmer A. Impact of accelerometer and pedometer use on physical activity and glycaemic control in people with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Medicine. 2017. https://doi.org/10.1111/dme.13331
  13. de Oliveira VLP, de Paula TP, Viana LV. Pedometer- and accelerometer- based physical activity interventions in Type 2 diabetes: A systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2024. https://doi.org/10.1016/j.numecd.2023.11.017

Everything in the library